glutathione for cirrhosis disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease Glutathione Reductase (GR) | The
Description
The catch: no published, peer-reviewed human randomized controlled trial exists for BPC-157 as of March 2026
not recommended
doi:10.1002/jor.21107 Preparation and storage Research-only handling information
At the starting dose of 2 mg per week, one vial lasts five weeks
In milder cases, deficiency may present as persistent fatigue, irritability, poor concentration, and digestive discomfort
Animals were treated either locally on the site of the anastomosis by a bath of 1 ml of NaBPC157 (2 g/ml or 2 ng/ml), intragastrically or intraperitoneally (10 g or 10 ng/kg b.w.) immediately after anastomosis formation
